Analysis of various nucleosides in plasma using solid phase extraction and high-performance liquid chromatography with UV detection

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.

Hiroaki Mitsuya, S Broder · Proceedings of the National Academy of Sciences · 1986 · 1K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells.

Mark Johnson, Gurpreet S. Ahluwalia, Michele Connelly et al. · Journal of Biological Chemistry · 1988 · 122 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity

David A. Cooney, Gurpreet S. Ahluwalia, Hiroaki Mitsuya et al. · Biochemical Pharmacology · 1987 · 102 citations

Life Sciences, Infectious Diseases, Pharmacology +11

Quantitation of didanosine in human plasma and urine by high-performance liquid chromatography

Catherine A. Knupp, Frank A. Stancato, E Papp et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1990 · 50 citations

Pharmacy, Biochemistry, Pharmaceutical Analysis +13

Comparative pharmacokinetics of new anti-HIV agents: 2', 3'-dideoxyadenosine and 2', 3'-dideoxyinosine

John W. Russell, Lewis J. Klunk · Biochemical Pharmacology · 1989 · 39 citations

Medicine, Pharmacokinetics, Pharmacology +10